FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

USV Private Olopatadine Hydrochloride Ophthalmic Recall

Olopatadine Hydrochloride Ophthalmic Solution USP 0

USV Private Limited

Risk level
Class II
Reported by FDA
Oct 29, 2025
Recall ID
D-0034-2026
Check your lot numberHow we source this data

Summary

USV Private recalled Olopatadine Hydrochloride Ophthalmic starting Oct 9, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0034-2026 on Oct 29, 2025. Reason: Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit. Status: Ongoing.

Why it was recalled

Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.

Product description

Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05

Lot numbers, UPCs & expiration codes

Lot #: 35000409, Exp. Date 01/2026

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0034-2026
Classification
Class II
Status
Ongoing
Recall initiated
Oct 9, 2025
FDA report date
Oct 29, 2025
Quantity
8,952 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
USV Private Limited

Original FDA data

Every field from FDA enforcement report D-0034-2026, exactly as published.

Show all FDA fields
City
Dabhel, Daman
Status
Ongoing
Country
India
Event ID
97766
Address
H-13, 16, 16a, 17, 18, 19, 20, 21 & E-22, Oidc, Mahatma Gandhi Udyog Nagar
Code information
Lot #: 35000409, Exp. Date 01/2026
Report date
Oct 29, 2025
Product type
Drugs
Recall number
D-0034-2026
Classification
Class II
Recalling firm
USV Private Limited
Product quantity
8,952 bottles
Reason for recall
Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05
Distribution pattern
Nationwide within the United States
Recall initiation date
Oct 9, 2025
Initial firm notification
Letter
Center classification date
Oct 20, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0034-2026, published Oct 29, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls